Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2025-01-14 00:00:00 ET · period of report 2025-01-10 · accession 0000950170-25-005353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-01-14 | 2025-01-10 | GMED | Pfeil Keith W | COO, CFO | M - OptEx | $51.78 | +14.2K | 5,833 | New | +$733.6K |
| DMT | 2025-01-14 | 2025-01-10 | GMED | Pfeil Keith W | COO, CFO | S - Sale+OE | $88.29 | -14.2K | 1,666 | -89% | -$1.25M |
| DMT | 2025-01-14 | 2025-01-10 | GMED | Pfeil Keith W | COO, CFO | M - OptEx | $0.00 | -14.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-01-10 | M | A | 8,334 | $53.27 | 14,167 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-01-10 | S | D | 1,666 | $89.17 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.69 to $89.63, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. |
| 3 | Common | Class A Common Stock | 2025-01-10 | S | D | 12,501 | $88.17 | 1,666 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.60 to $88.55, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. |
| 4 | Common | Class A Common Stock | 2025-01-10 | M | A | 5,833 | $49.65 | 5,833 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2025-01-10 | M | D | 8,334 | $0.00 | 833 | D | $53.27 · — to 2030-01-22 | 8,334 Class A Common Stock | (F5) These options were granted on January 22, 2020 and are fully vested. |
| 6 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2025-01-10 | M | D | 5,833 | $0.00 | 0 | D | $49.65 · — to 2029-09-03 | 5,833 Class A Common Stock | (F4) These options were granted on September 3, 2019 and are fully vested. |